Publication | Closed Access

Lack of efficacy of mitoxantrone in primary progressive Multiple Sclerosis irrespective of pharmacogenetic factors: A multi-center, retrospective analysis

Pharmacogenetic FactorsNeurological DisorderMedicinePharmacologyRetrospective AnalysisNeurological ProgressPharmacotherapyNeurologyMultiple SclerosisNeuroimmunology